Quick Take
- MediBuddy Revenue Rises to Rs 1,500 Cr in FY26, up roughly 20% year-on-year.
- Q4 FY26 is MediBuddy’s first EBITDA-positive quarter in its 12-year history.
- Full-year burn fell 60% as B2B enterprise sales crossed 75% of total revenue.
MediBuddy revenue rises to Rs 1,500 Cr (approximately $178 Mn) in FY26, growing roughly 20% year-on-year as the company delivers its first-ever profitable quarter.
The Q4 January-March 2026 result marks MediBuddy’s first positive EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation, a standard measure of operating profitability) quarter. Founded in 2013 in Bengaluru, the company has scaled six times in five years. Its B2B (Business-to-Business, selling services to companies rather than individual consumers) model earns over 75% of revenue from corporate and insurance clients, driving both growth and margin discipline.
StartupFeed Insight
A 75% B2B revenue concentration is unusual for consumer health platforms. It means MediBuddy’s income is sticky, renews annually through corporate contracts, and compounds as employers add headcount. Combine that with a 60% burn cut and a 15% margin improvement in a single year, and the EBITDA turn looks structural rather than a one-quarter blip. HR and procurement heads at India’s mid-to-large corporates should watch whether MediBuddy bundles vision, fitness, and mental health into one employer wallet. That bundling play, if executed at scale, could make MediBuddy a required line item in corporate wellness budgets for India’s top 500 companies by Q4 FY28, StartupFeed Desk.
How Did MediBuddy Revenue Rises Stack Up in FY26?
| Metric | Detail | Notes |
|---|---|---|
| Annual Revenue (FY26) | Rs 1,500 Cr+ (~$178 Mn) | Up ~20% year-on-year |
| Q4 FY26 EBITDA | Positive (first ever) | Company’s first profitable quarter |
| Full-Year Burn Reduction | ~60% | Improved cost discipline across operations |
| Margin Profile Improvement | ~15% | Better unit economics year-on-year |
| B2B Revenue Share | 75%+ of total | Enterprise clients and insurance partners |
| Online Consultation Growth | Over 90% YoY | Q4 FY26 period |
| Subscription and Preventive Care | Over 50% YoY growth | Long-term health management programs |
| Revenue vs. FY21 | ~6x higher | Five-year growth trajectory |
The 90%-plus growth in online consultations stands out. It shows digital healthcare has moved from a pandemic-era habit to a sustained consumer preference in India.
About MediBuddy
MediBuddy (legal name: Phasorz Technologies Private Limited) is a Bengaluru-based digital healthcare platform founded in 2013 by Satish Kannan (CEO) and Enbasekar Dinadayalane (CTO), both IIT Madras alumni. The company connects patients with 140,000-plus doctors across 22-plus specialties, 7,500-plus hospitals, 7,700-plus diagnostic centres, and 10,000-plus pharmacies. MediBuddy has raised $193 Mn in total across 13 rounds. Key investors include Quadria Capital, Lightrock India, and Bessemer Venture Partners.
Is MediBuddy Profitable in FY26?
MediBuddy turned EBITDA-positive in Q4 FY26, marking its first profitable quarter. The company has not disclosed full-year PAT (Profit After Tax, the bottom-line number after all charges). The Q4 result is still meaningful: it shows the company’s core operations now generate more cash than they consume. CEO Satish Kannan addressed the milestone directly:
“Achieving a positive quarter marks a defining inflection point in MediBuddy’s journey. It validates the scalability of our business model and reflects sustained improvements in unit economics, disciplined cost management, and operational rigour throughout the organisation.”
Satish Kannan, CEO and Co-founder, MediBuddy.
One operational highlight underlines the scale. MediBuddy served more than 100,000 unique consumers in a single day during FY26. The company says that figure exceeds the daily reach of any single hospital chain in India. Diagnostic services also set new monthly collection volume records, and newer verticals such as vision care and fitness programs added fresh demand streams.
How Does MediBuddy Compare to Competitors?
The MediBuddy revenue rises of recent years place it between India’s two best-known digital health peers on revenue size, while outperforming both on recent burn discipline.
| Company | Revenue (Latest Disclosed) | EBITDA Status | Primary Model |
|---|---|---|---|
| MediBuddy | Rs 1,500 Cr+ (FY26) | Positive (Q4 FY26) | B2B enterprise + full-stack health |
| Tata 1mg | Rs 2,392 Cr (FY25) | Loss (Rs 276 Cr) | E-pharmacy + diagnostics (B2C) |
| Practo | Rs 234 Cr (FY25) | Positive (Rs 15 Cr) | B2B SaaS + online consultations |
Note: Tata 1mg and Practo figures are for FY25, the most recently disclosed period. MediBuddy FY26 data is from the company’s press release dated May 15, 2026.
MediBuddy sits in the middle of the revenue range. It is larger than Practo and EBITDA-positive like Practo, but smaller than Tata 1mg by revenue. Its enterprise-first model gives it an advantage neither peer fully replicates at the same scale.
What’s Next
MediBuddy has not announced a public listing (IPO) timeline. The EBITDA inflection and the 60% burn reduction, however, bring a listing conversation closer. Watch for two near-term signals: whether the company discloses full-year PAT in its MCA (Ministry of Corporate Affairs) filing for FY26, and whether it raises a pre-IPO round before the end of FY27. The company serves 10 lakh-plus unique customers each year. Can that base grow to 20 lakh by FY28 while staying EBITDA-positive?
Frequently Asked Questions
How much revenue did MediBuddy earn in FY26, and from whom?
MediBuddy posted annual revenue of Rs 1,500 Cr-plus (approximately $178 Mn) in FY26, growing roughly 20% year-on-year. Over 75% of that revenue came from B2B enterprise clients and insurance partners. The company also recorded its first EBITDA-positive quarter in Q4 FY26, reducing its full-year burn by roughly 60%.
What does MediBuddy do and who founded it?
MediBuddy is a Bengaluru-based digital healthcare platform founded in 2013 by Satish Kannan and Enbasekar Dinadayalane, both IIT Madras alumni. It offers online doctor consultations, diagnostic lab bookings, medicine delivery, mental health services, and corporate wellness programs. The company has raised $193 Mn in total funding, with Quadria Capital and Lightrock India as lead investors from the Series C round.
Is MediBuddy profitable, and what is its IPO plan?
MediBuddy turned EBITDA-positive in Q4 FY26, its first profitable quarter. Full-year PAT figures have not been disclosed. The company has not announced an IPO plan. The burn reduction of roughly 60% and the margin improvement of roughly 15% suggest profitability is on track, but a listing would likely require at least two to three more consecutive EBITDA-positive quarters.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. StartupFeed and its authors are not SEBI-registered investment advisors. The analysis above is based on publicly available information and should not be the sole basis for any investment decision. Please consult a SEBI-registered financial advisor before making investment decisions.
Have a tip? Write to us at editorial@startupfeed.in.
